Induced pluripotent stem cells share proteins with some cancers. The cells can be used as a vaccine to prevent pancreatic cancers in mice.
A revolutionaly technique helps cure 9-year-old girl who was Stanford Children's Health's 1,000th stem cell transplant patient.
ESPN told the story of Stanford football coach David Shaw donating stem cells to save his brother, who had a rare form of lymphoma.
Stanford researchers have several projects underway to improve imaging techniques, bracing treatment and surgeries for kids and teens with scoliosis.
Stanford stem cell biologists have found a way to block a signal that causes growth of breast cancer cells, opening potential for new treatments.
An innovative stem cell delivery method vastly improves the viability of tissue regenerating cells in animal spinal-cord injury models.
This "In the Spotlight" features Carolyn Dundes, a PhD candidate in Stanford's Stem Cell Biology and Regenerative Medicine program and an LGBTQ advocate.
Stanford researchers study stem-cell-derived human heart muscle cells on the International Space Station to learn effects of microgravity.
Stanford scientists have conducted a proof-of-concept experiment in mice that shows they can use blood stem cells to treat a severe brain disease.
A method that broadens the pool of potential donors for stem cell transplants recently saved two young brothers from a severe genetic disease.
A state-of-the-field review of stem cell research by Stanford's Helen Blau reveals their promise & exposes problems in the path to clinical applications.
Using a lab model, Stanford researchers identified a type of developing brain cell that is profoundly changed by exposure to low oxygen levels.
Stanford scientists and collaborators have harnessed CRISPR to replace the mutated gene underpinning the devastating immune disease, SCID-X1.
This In the Spotlight features Kyle Loh, a stem cell researcher who is working to create pure populations of cells. He also enjoys road bicycling.
Antibody-based hematopoietic stem cell transplants may transform the treatment of patients with blood and immune diseases including cancers.
A team of researchers have found a new way to remove blood-producing stem cells, introducing the possibility of safer, and non-matched, transplants.